ADC Therapeutics is a clinical-stage oncology biotechnology company leading the development and commercialization of next-generation antibody drug conjugates (ADCs) with highly potent and targeted pyrrolobenzodiazepine (PBD) dimer technology.

Biotechnology

ADC Therapeutics

Ameet Mallik

Jason Moss

Alan S.

Ruchi Mallya

Niall McConnell

Jesse Stromeyer

Stephen Dudek

Jay Feingold

Lisa Källebo

Jada Baijnath

Michelle Celones

Mohamed Zaki

Kristen Harrington-Smith

Jose Carmona

Kimberly Pope

Peter Graham

Patrick van Berkel

Susan Romanus

Michael Mulkerrin

The executive team at ADC Therapeutics has a history of experience in finance, business, and economics from companies such as Celgene, Genocea, ImmunoGen, Inc., and MorphoSys. They also have experience in human resources from companies such as IDEX Corporation and Hospira.

CEO and Executive Team

Leadership Team

Board of Directors

CEO and Executive Team

About

Team members

Other teams at ADC Therapeutics

Leadership Team

Board of Directors